Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohydrates), Inorganic Chemicals (Calcium Phosphate)), Functionality (Fillers, Binders, Lubricants, Preservatives), Formulation (Tablets, Capsules, Parenteral)- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 57)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
                    FIGURE 1 PHARMACEUTICAL EXCIPIENTS MARKET
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 61)
    2.1 RESEARCH DATA
          FIGURE 2 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                    FIGURE 3 BREAKDOWN OF PRIMARIES BY RESPONDENT, DESIGNATION, AND REGION: PHARMACEUTICAL EXCIPIENTS MARKET
    2.2 MARKET ESTIMATION METHODOLOGY
          FIGURE 4 GLOBAL MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2021
          FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2021
           2.2.1 INSIGHTS FROM PRIMARY EXPERTS
                    FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
    2.3 MARKET GROWTH RATE PROJECTIONS
          FIGURE 7 GLOBAL MARKET (SUPPLY SIDE): CAGR PROJECTIONS
          FIGURE 8 GLOBAL MARKET (DEMAND-SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS
           2.3.1 DATA TRIANGULATION
                    FIGURE 9 DATA TRIANGULATION METHODOLOGY
    2.4 RESEARCH ASSUMPTIONS
           2.4.1 COVID-19 ASSUMPTIONS
    2.5 RISK ANALYSIS

3 EXECUTIVE SUMMARY (Page No. - 70)
    FIGURE 10 PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2022 VS. 2030  
    FIGURE 11 GLOBAL MARKET, BY FUNCTIONALITY, 2022 VS. 2030  
    FIGURE 12 GLOBAL MARKET, BY FORMULATION, 2022 VS. 2030  
    FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE GLOBAL MARKET

4 PREMIUM INSIGHTS (Page No. - 73)
    4.1 PHARMACEUTICAL EXCIPIENTS: MARKET OVERVIEW
          FIGURE 14 GROWING PHARMACEUTICALS INDUSTRY, COUPLED WITH ADVANCEMENTS IN FUNCTIONAL EXCIPIENTS, ARE KEY FACTORS DRIVING MARKET GROWTH
    4.2 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY FORMULATION AND COUNTRY (2022)
          FIGURE 15 ORAL FORMULATIONS ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021
    4.3 PHARMACEUTICALS EXCIPIENTS MARKET SHARE, BY PRODUCT, 2022 VS. 2030
          FIGURE 16 ORGANIC CHEMICALS SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2030
    4.4 GLOBAL MARKET SHARE, BY FORMULATION, 2022
          FIGURE 17 ORAL FORMULATIONS SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2022
    4.5 GLOBAL MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
          FIGURE 18 ASIA PACIFIC COUNTRIES TO SHOW THE HIGHEST GROWTH DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 76)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
          FIGURE 19 PHARMACEUTICAL EXCIPIENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
          TABLE 1 GLOBAL MARKET: IMPACT ANALYSIS
           5.2.1 DRIVERS
                    5.2.1.1 Growth of the pharmaceuticals market backed by functional excipients
                                FIGURE 20 GLOBAL PHARMACEUTICAL DRUG SALES (2008–2022)
                    5.2.1.2 Surge in the generics market
                                TABLE 2 DRUG PATENT EXPIRY, BY YEAR
                    5.2.1.3 Increasing uptake of biopharmaceuticals
                    5.2.1.4 Rising adoption of orphan drugs
                                FIGURE 21 INCREASING PENETRATION OF ORPHAN DRUGS (2010–2024)
                                FIGURE 22 RISING NUMBER OF ORPHAN INDICATIONS APPROVED IN THE US
           5.2.2 RESTRAINTS
                    5.2.2.1 Cost and time-intensive drug development process
                    5.2.2.2 Increasing regulatory stringency
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Multifunctional excipients
                                TABLE 3 MULTIFUNCTIONAL EXCIPIENTS
                    5.2.3.2 Shifting focus of pharmaceutical manufacturing to emerging countries
                    5.2.3.3 Growth in the biosimilars market
           5.2.4 CHALLENGES
                    5.2.4.1 Safety and quality concerns
                    5.2.4.2 Changing trade policies
           5.2.5 INDUSTRY TRENDS
                    5.2.5.1 Rising demand for co-processed excipients
                                TABLE 4 MARKETED CO-PROCESSED EXCIPIENTS
                    5.2.5.2 Improving excipient capabilities using nanotechnology
                    5.2.5.3 Increasing use of direct compression in oral dosage formulations
                    5.2.5.4 Pharmaceutical excipients influencing the cost of production
    5.3 RANGES/SCENARIO
          FIGURE 23 SPECTRUM OF SCENARIOS BASED ON THE IMPACT OF UNCERTAINTIES ON THE GROWTH OF THE PHARMACEUTICAL EXCIPIENTS MARKET
    5.4 IMPACT OF COVID-19 ON THE GLOBAL MARKET
          FIGURE 24 INCREASE IN REVENUE, BY QUARTER
          FIGURE 25 COVID-19 IMPACT ON SECTIONS OF THE PHARMACEUTICAL INDUSTRY
          FIGURE 26 GLOBAL MARKET SCENARIO WITH AND WITHOUT COVID-19 IMPACT, 2019-2021
    5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
          FIGURE 27 REVENUE SHIFT AND NEW POCKETS FOR PHARMACEUTICAL EXCIPIENTS PROVIDERS
    5.6 TRADE DATA
           5.6.1 SUCROSE
           5.6.2 PREPARED BINDERS FOR MOLDS/CORES, CHEMICAL PRODUCTS, AND PREPARATION FOR CHEMICAL INDUSTRIES
           5.6.3 MANNITOL (ACYCLIC ALCOHOLS & THEIR DERIVATIVES)
           5.6.4 CELLULOSE
    5.7 INDICATIVE PRICING MODEL ANALYSIS
           5.7.1 US
           5.7.2 CHINA
           5.7.3 INDIA
    5.8 VALUE CHAIN ANALYSIS
          FIGURE 28 VALUE CHAIN ANALYSIS OF THE PHARMACEUTICAL EXCIPIENTS MARKET
    5.9 SUPPLY CHAIN ANALYSIS
          FIGURE 29 MARKET: SUPPLY CHAIN ANALYSIS
    5.10 ECOSYSTEM ANALYSIS
           FIGURE 30 ECOSYSTEM ANALYSIS: GLOBAL MARKET
           TABLE 5 SUPPLY CHAIN ECOSYSTEM
    5.11 PATENT ANALYSIS
           FIGURE 31 PATENT APPLICATIONS FOR THE GLOBAL MARKET, JANUARY 2012–MAY 2022
           TABLE 6 INDICATIVE LIST OF PATENTS IN THE GLOBAL MARKET
    5.12 KEY CONFERENCES AND EVENTS, 2022–2023
           TABLE 7 CONFERENCES, 2022–2023
    5.13 REGULATORY ANALYSIS
           5.13.1 NORTH AMERICA
                    5.13.1.1 US
                    5.13.1.2 Canada
           5.13.2 EUROPE
           5.13.3 ASIA PACIFIC
                    5.13.3.1 Japan
                    5.13.3.2 China
                    5.13.3.3 India
    5.14 PORTER’S FIVE FORCES ANALYSIS
           TABLE 8 PHARMACEUTICAL EXCIPIENTS MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.14.1 THREAT OF NEW ENTRANTS
           5.14.2 THREAT OF SUBSTITUTES
           5.14.3 BARGAINING POWER OF BUYERS
           5.14.4 BARGAINING POWER OF SUPPLIERS
           5.14.5 DEGREE OF COMPETITION
    5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
           5.15.1 KEY STAKEHOLDERS IN COMPANIES AND THEIR INFLUENCE ON THE BUYING PROCESS
                     FIGURE 32 INFLUENCE OF COMPANY STAKEHOLDERS IN THE BUYING PROCESS OF PHARMACEUTICAL EXCIPIENTS PRODUCTS
           5.15.2 KEY BUYING CRITERIA FOR PHARMACEUTICAL EXCIPIENT PRODUCTS AMONG END USERS
                     FIGURE 33 KEY BUYING CRITERIA FOR END USERS

6 PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT (Page No. - 110)
    6.1 INTRODUCTION
          TABLE 9 PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2022–2030  
    6.2 ORGANIC CHEMICALS
          TABLE 10 GLOBAL MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2022–2030  
          TABLE 11 GLOBAL MARKET FOR ORGANIC CHEMICALS, BY REGION, 2022–2030  
          TABLE 12 NORTH AMERICA: MARKET FOR ORGANIC CHEMICALS, BY COUNTRY, 2022–2030  
          TABLE 13 EUROPE: MARKET FOR ORGANIC CHEMICALS, BY COUNTRY, 2022–2030  
          TABLE 14 ASIA PACIFIC: MARKET FOR ORGANIC CHEMICALS, BY COUNTRY, 2022–2030  
           6.2.1 OLEOCHEMICALS
                    TABLE 15 OLEOCHEMICALS MARKET, BY TYPE, 2022–2030  
                    TABLE 16 OLEOCHEMICALS MARKET, BY REGION, 2022–2030  
                    TABLE 17 NORTH AMERICA: OLEOCHEMICALS MARKET, BY COUNTRY, 2022–2030  
                    TABLE 18 EUROPE: OLEOCHEMICALS MARKET, BY COUNTRY, 2022–2030  
                    TABLE 19 ASIA PACIFIC: OLEOCHEMICALS MARKET, BY COUNTRY, 2022–2030  
                    6.2.1.1 Fatty alcohols
                               6.2.1.1.1 Fatty alcohols are widely used as nonionic surfactants due to their amphipathic nature—a major driver for market growth
                                              TABLE 20 FATTY ALCOHOLS MARKET, BY REGION, 2022–2030  
                                              TABLE 21 NORTH AMERICA: FATTY ALCOHOLS MARKET, BY COUNTRY, 2022–2030  
                                              TABLE 22 EUROPE: FATTY ALCOHOLS MARKET, BY COUNTRY, 2022–2030  
                                              TABLE 23 ASIA PACIFIC: FATTY ALCOHOLS MARKET, BY COUNTRY, 2022–2030  
                    6.2.1.2 Mineral stearates
                               6.2.1.2.1 Wide use of magnesium stearates as excipients in nutraceutical and pharmaceutical formulations to drive market growth
                                              TABLE 24 METAL STEARATES MARKET, BY REGION, 2022–2030  
                                              TABLE 25 NORTH AMERICA: METAL STEARATES MARKET, BY COUNTRY, 2022–2030  
                                              TABLE 26 EUROPE: METAL STEARATES MARKET, BY COUNTRY, 2022–2030  
                                              TABLE 27 ASIA PACIFIC: METAL STEARATES MARKET, BY COUNTRY, 2022–2030  
                    6.2.1.3 Glycerin
                               6.2.1.3.1 Extensive applications of glycerin to drive market growth
                                              TABLE 28 GLYCERIN MARKET, BY REGION, 2022–2030  
                                              TABLE 29 NORTH AMERICA: GLYCERIN MARKET, BY COUNTRY, 2022–2030  
                                              TABLE 30 EUROPE: GLYCERIN MARKET, BY COUNTRY, 2022–2030  
                                              TABLE 31 ASIA PACIFIC: GLYCERIN MARKET, BY COUNTRY, 2022–2030  
                    6.2.1.4 Other oleochemicals
                                 TABLE 32 OTHER OLEOCHEMICALS MARKET, BY REGION, 2022–2030  
                                 TABLE 33 NORTH AMERICA: OTHER OLEOCHEMICALS MARKET, BY COUNTRY, 2022–2030  
                                 TABLE 34 EUROPE: OTHER OLEOCHEMICALS MARKET, BY COUNTRY, 2022–2030  
                                 TABLE 35 ASIA PACIFIC: OTHER OLEOCHEMICALS MARKET, BY COUNTRY, 2022–2030  
           6.2.2 CARBOHYDRATES
                    TABLE 36 CARBOHYDRATES MARKET, BY TYPE, 2022–2030  
                    TABLE 37 CARBOHYDRATES MARKET, BY REGION, 2022–2030  
                    TABLE 38 NORTH AMERICA: CARBOHYDRATES MARKET, BY COUNTRY, 2022–2030  
                    TABLE 39 EUROPE: CARBOHYDRATES MARKET, BY COUNTRY, 2022–2030  
                    TABLE 40 ASIA PACIFIC: CARBOHYDRATES MARKET, BY COUNTRY, 2022–2030  
                    6.2.2.1 Sugars
                                 TABLE 41 SUGARS MARKET, BY TYPE, 2022–2030  
                                 TABLE 42 SUGARS MARKET, BY REGION, 2022–2030  
                                 TABLE 43 NORTH AMERICA: SUGARS MARKET, BY COUNTRY, 2022–2030  
                                 TABLE 44 EUROPE: SUGARS MARKET, BY COUNTRY, 2022–2030  
                                 TABLE 45 ASIA PACIFIC: SUGARS MARKET, BY COUNTRY, 2022–2030  
                               6.2.2.1.1 Actual sugars
                                             6.2.2.1.1.1 Growing use of actual sugars in pediatric formulations drives the market growth
                                                              TABLE 46 ACTUAL SUGARS MARKET, BY REGION, 2022–2030  
                                                              TABLE 47 NORTH AMERICA: ACTUAL SUGARS MARKET, BY COUNTRY, 2022–2030  
                                                              TABLE 48 EUROPE: ACTUAL SUGARS MARKET, BY COUNTRY, 2022–2030  
                                                              TABLE 49 ASIA PACIFIC: ACTUAL SUGARS MARKET, BY COUNTRY, 2022–2030  
                               6.2.2.1.2 Sugar alcohols
                                             6.2.2.1.2.1 Mannitol to show the highest growth in the market for sugar alcohols
                                                              TABLE 50 SUGAR ALCOHOLS MARKET, BY REGION, 2022–2030  
                                                              TABLE 51 NORTH AMERICA: SUGAR ALCOHOLS MARKET, BY COUNTRY, 2022–2030  
                                                              TABLE 52 EUROPE: SUGAR ALCOHOLS MARKET, BY COUNTRY, 2022–2030  
                                                              TABLE 53 ASIA PACIFIC: SUGAR ALCOHOLS MARKET, BY COUNTRY, 2022–2030  
                               6.2.2.1.3 Artificial sweeteners
                                             6.2.2.1.3.1 Aspartame is the most used artificial sweetener
                                                              TABLE 54 ARTIFICIAL SWEETENERS MARKET, BY REGION, 2022–2030  
                                                              TABLE 55 NORTH AMERICA: ARTIFICIAL SWEETENERS MARKET, BY COUNTRY, 2022–2030  
                                                              TABLE 56 EUROPE: ARTIFICIAL SWEETENERS MARKET, BY COUNTRY, 2022–2030  
                                                              TABLE 57 ASIA PACIFIC: ARTIFICIAL SWEETENERS MARKET, BY COUNTRY, 2022–2030  
                    6.2.2.2 Cellulose
                                 TABLE 58 CELLULOSE MARKET BY TYPE, 2022–2030  
                                 TABLE 59 CELLULOSE MARKET BY REGION, 2022–2030  
                                 TABLE 60 NORTH AMERICA: CELLULOSE MARKET BY COUNTRY, 2022–2030  
                                 TABLE 61 EUROPE: CELLULOSE MARKET BY COUNTRY, 2022–2030  
                                 TABLE 62 ASIA PACIFIC: CELLULOSE MARKET BY COUNTRY, 2022–2030  
                               6.2.2.2.1 Microcrystalline cellulose
                                             6.2.2.2.1.1 Microcrystalline cellulose is the most widely used excipient in the direct compression method for tablets
                                                              TABLE 63 MICROCRYSTALLINE CELLULOSE MARKET, BY REGION, 2022–2030  
                                                              TABLE 64 NORTH AMERICA: MICROCRYSTALLINE CELLULOSE MARKET, BY COUNTRY, 2022–2030  
                                                              TABLE 65 EUROPE: MICROCRYSTALLINE CELLULOSE MARKET, BY COUNTRY, 2022–2030  
                                                              TABLE 66 ASIA PACIFIC: MICROCRYSTALLINE CELLULOSE MARKET, BY COUNTRY, 2022–2030  
                               6.2.2.2.2 Cellulose ethers
                                             6.2.2.2.2.1 Cellulose ethers are effective even at a lower concentration
                                                              TABLE 67 CELLULOSE ETHERS MARKET, BY REGION, 2022–2030  
                                                              TABLE 68 NORTH AMERICA: CELLULOSE ETHERS MARKET, BY COUNTRY, 2022–2030  
                                                              TABLE 69 EUROPE: CELLULOSE ETHERS MARKET, BY COUNTRY, 2022–2030  
                                                              TABLE 70 ASIA PACIFIC: CELLULOSE ETHERS MARKET, BY COUNTRY, 2022–2030  
                               6.2.2.2.3 CMC & croscarmellose sodium
                                             6.2.2.2.3.1 Multiple advantages of CMC and croscarmellose sodium make them the most widely used suspending agents in injectable preparations
                                                              TABLE 71 CMC & CROSCARMELLOSE SODIUM MARKET, BY REGION, 2022–2030  
                                                              TABLE 72 NORTH AMERICA: CMC & CROSCARMELLOSE SODIUM MARKET, BY COUNTRY, 2022–2030  
                                                              TABLE 73 EUROPE: CMC & CROSCARMELLOSE SODIUM MARKET, BY COUNTRY, 2022–2030  
                                                              TABLE 74 ASIA PACIFIC: CMC & CROSCARMELLOSE SODIUM MARKET, BY COUNTRY, 2022–2030  
                               6.2.2.2.4 Cellulose esters
                                             6.2.2.2.4.1 Cellulose esters enable the delivery of drugs in cellular membranes and the intracellular matrix
                                                              TABLE 75 CELLULOSE ESTERS MARKET, BY REGION, 2022–2030  
                                                              TABLE 76 NORTH AMERICA: CELLULOSE ESTERS MARKET, BY COUNTRY, 2022–2030  
                                                              TABLE 77 EUROPE: CELLULOSE ESTERS MARKET, BY COUNTRY, 2022–2030  
                                                              TABLE 78 ASIA PACIFIC: CELLULOSE ESTERS MARKET, BY COUNTRY, 2022–2030  
                    6.2.2.3 Starch
                                 TABLE 79 STARCH MARKET, BY TYPE, 2022–2030  
                                 TABLE 80 STARCH MARKET, BY REGION, 2022–2030  
                                 TABLE 81 NORTH AMERICA: STARCH MARKET, BY COUNTRY, 2022–2030  
                                 TABLE 82 EUROPE: STARCH MARKET, BY COUNTRY, 2022–2030  
                                 TABLE 83 ASIA PACIFIC: STARCH MARKET, BY COUNTRY, 2022–2030  
                               6.2.2.3.1 Modified starch
                                             6.2.2.3.1.1 Modified starch is widely used in sustained-release tablets due to its cold-water swelling and gel barrier formation capabilities
                                                              TABLE 84 MODIFIED STARCH MARKET, BY REGION, 2022–2030  
                                                              TABLE 85 NORTH AMERICA: MODIFIED STARCH MARKET, BY COUNTRY, 2022–2030  
                                                              TABLE 86 EUROPE: MODIFIED STARCH MARKET, BY COUNTRY, 2022–2030  
                                                              TABLE 87 ASIA PACIFIC: MODIFIED STARCH MARKET, BY COUNTRY, 2022–2030  
                               6.2.2.3.2 Dried starch
                                             6.2.2.3.2.1 Dried starch is a strong binding and coating agent
                                                              TABLE 88 DRIED STARCH MARKET, BY REGION, 2022–2030  
                                                              TABLE 89 NORTH AMERICA: DRIED STARCH MARKET, BY COUNTRY, 2022–2030  
                                                              TABLE 90 EUROPE: DRIED STARCH MARKET, BY COUNTRY, 2022–2030  
                                                              TABLE 91 ASIA PACIFIC: DRIED STARCH MARKET, BY COUNTRY, 2022–2030  
                               6.2.2.3.3 Converted starch
                                             6.2.2.3.3.1 Converted starch is used as a molecular encapsulation agent and offers enhanced solubility and stability for drugs
                                                              TABLE 92 CONVERTED STARCH MARKET, BY REGION, 2022–2030  
                                                              TABLE 93 NORTH AMERICA: CONVERTED STARCH MARKET, BY COUNTRY, 2022–2030  
                                                              TABLE 94 EUROPE: CONVERTED STARCH MARKET, BY COUNTRY, 2022–2030  
                                                              TABLE 95 ASIA PACIFIC: CONVERTED STARCH MARKET, BY COUNTRY, 2022–2030  
           6.2.3 PETROCHEMICALS
                    TABLE 96 PETROCHEMICALS MARKET, BY TYPE, 2022–2030  
                    TABLE 97 PETROCHEMICALS MARKET, BY REGION, 2022–2030  
                    TABLE 98 NORTH AMERICA: PETROCHEMICALS MARKET, BY COUNTRY, 2022–2030  
                    TABLE 99 EUROPE: PETROCHEMICALS MARKET, BY COUNTRY, 2022–2030  
                    TABLE 100 ASIA PACIFIC: PETROCHEMICALS MARKET, BY COUNTRY, 2022–2030  
                    6.2.3.1 Glycols
                               6.2.3.1.1 The availability of highly purified polyethylene glycol to enhance stability has driven the demand
                                              TABLE 101 GLYCOLS MARKET, BY REGION, 2022–2030  
                                              TABLE 102 NORTH AMERICA: GLYCOLS MARKET, BY COUNTRY, 2022–2030  
                                              TABLE 103 EUROPE: GLYCOLS MARKET, BY COUNTRY, 2022–2030  
                                              TABLE 104 ASIA PACIFIC: GLYCOLS MARKET, BY COUNTRY, 2022–2030  
                    6.2.3.2 Povidones
                               6.2.3.2.1 Rising demand for fast-dissolving tablets is expected to propel the growth of this segment
                                              TABLE 105 POVIDONES MARKET, BY REGION, 2022–2030  
                                              TABLE 106 NORTH AMERICA: POVIDONES MARKET, BY COUNTRY, 2022–2030  
                                              TABLE 107 EUROPE: POVIDONES MARKET, BY COUNTRY, 2022–2030  
                                              TABLE 108 ASIA PACIFIC: POVIDONES MARKET, BY COUNTRY, 2022–2030  
                    6.2.3.3 Mineral hydrocarbons
                               6.2.3.3.1 Growing preference for topical formulations in pain management has supported the demand for mineral hydrocarbons
                                              TABLE 109 MINERAL HYDROCARBONS MARKET, BY REGION, 2022–2030  
                                              TABLE 110 NORTH AMERICA: MINERAL HYDROCARBONS MARKET, BY COUNTRY, 2022–2030  
                                              TABLE 111 EUROPE: MINERAL HYDROCARBONS MARKET, BY COUNTRY, 2022–2030  
                                              TABLE 112 ASIA PACIFIC: MINERAL HYDROCARBONS MARKET, BY COUNTRY, 2022–2030  
                    6.2.3.4 Acrylic polymers
                               6.2.3.4.1 Wide use of acrylic polymers in controlled-release drug formulations to drive market growth
                                              TABLE 113 ACRYLIC POLYMERS MARKET, BY REGION, 2022–2030  
                                              TABLE 114 NORTH AMERICA: ACRYLIC POLYMERS MARKET, BY COUNTRY, 2022–2030  
                                              TABLE 115 EUROPE: ACRYLIC POLYMERS MARKET, BY COUNTRY, 2022–2030  
                                              TABLE 116 ASIA PACIFIC: ACRYLIC POLYMERS MARKET, BY COUNTRY, 2022–2030  
                    6.2.3.5 Other petrochemical excipients
                                TABLE 117 OTHER PETROCHEMICAL EXCIPIENTS MARKET, BY REGION, 2022–2030  
                                TABLE 118 NORTH AMERICA: OTHER PETROCHEMICAL EXCIPIENTS MARKET, BY COUNTRY, 2022–2030  
                                TABLE 119 EUROPE: OTHER PETROCHEMICAL EXCIPIENTS MARKET, BY COUNTRY, 2022–2030  
                                TABLE 120 ASIA PACIFIC: OTHER PETROCHEMICAL EXCIPIENTS MARKET, BY COUNTRY, 2022–2030  
           6.2.4 PROTEINS
                    6.2.4.1 Growing applications of proteins as carriers for microparticles and nanoparticles to drive market growth
                                TABLE 121 PROTEINS MARKET, BY REGION, 2022–2030  
                                TABLE 122 NORTH AMERICA: PROTEINS MARKET, BY COUNTRY, 2022–2030  
                                TABLE 123 EUROPE: PROTEINS MARKET, BY COUNTRY, 2022–2030  
                                TABLE 124 ASIA PACIFIC: PROTEINS MARKET, BY COUNTRY, 2022–2030  
           6.2.5 OTHER ORGANIC CHEMICALS
                    TABLE 125 OTHER ORGANIC CHEMICALS MARKET, BY REGION, 2022–2030  
                    TABLE 126 NORTH AMERICA: OTHER ORGANIC CHEMICALS MARKET, BY COUNTRY, 2022–2030  
                    TABLE 127 EUROPE: OTHER ORGANIC CHEMICALS MARKET, BY COUNTRY, 2022–2030  
                    TABLE 128 ASIA PACIFIC: OTHER ORGANIC CHEMICALS MARKET, BY COUNTRY, 2022–2030  
    6.3 INORGANIC CHEMICALS
          TABLE 129 PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2022–2030  
          TABLE 130 GLOBAL MARKET FOR INORGANIC CHEMICALS, BY REGION, 2022–2030  
          TABLE 131 NORTH AMERICA: MARKET FOR INORGANIC CHEMICALS, BY COUNTRY, 2022–2030  
          TABLE 132 EUROPE: MARKET FOR INORGANIC CHEMICALS, BY COUNTRY, 2022–2030  
          TABLE 133 ASIA PACIFIC: MARKET FOR INORGANIC CHEMICALS, BY COUNTRY, 2022–2030  
           6.3.1 CALCIUM PHOSPHATE
                    6.3.1.1 Chemical purity and low incompatibility with drugs aid their high usage in the pharmaceutical industry
                                TABLE 134 CALCIUM PHOSPHATE MARKET, BY REGION, 2022–2030  
                                TABLE 135 NORTH AMERICA: CALCIUM PHOSPHATE MARKET, BY COUNTRY, 2022–2030  
                                TABLE 136 EUROPE: CALCIUM PHOSPHATE MARKET, BY COUNTRY, 2022–2030  
                                TABLE 137 ASIA PACIFIC: CALCIUM PHOSPHATE MARKET, BY COUNTRY, 2022–2030  
           6.3.2 METAL OXIDES
                    6.3.2.1 Availability of silicon oxides in the hydrophobic, hydrophilic, and granulated forms to aid market growth
                                TABLE 138 METAL OXIDES MARKET, BY REGION, 2022–2030  
                                TABLE 139 NORTH AMERICA: METAL OXIDES MARKET, BY COUNTRY, 2022–2030  
                                TABLE 140 EUROPE: METAL OXIDES MARKET, BY COUNTRY, 2022–2030  
                                TABLE 141 ASIA PACIFIC: METAL OXIDES MARKET, BY COUNTRY, 2022–2030  
           6.3.3 HALITES
                    6.3.3.1 Increased utilization of halites in vaccines and controlled-release formulations is driving their demand in the market
                                TABLE 142 HALITES MARKET, BY REGION, 2022–2030  
                                TABLE 143 NORTH AMERICA: HALITES MARKET, BY COUNTRY, 2022–2030  
                                TABLE 144 EUROPE: HALITES MARKET, BY COUNTRY, 2022–2030  
                                TABLE 145 ASIA PACIFIC: HALITES MARKET, BY COUNTRY, 2022–2030  
           6.3.4 CALCIUM CARBONATE
                    6.3.4.1 Properties such as short disintegration time and excellent mechanical strength for oral dosage formulations to drive the market
                                TABLE 146 CALCIUM CARBONATE MARKET, BY REGION, 2022–2030  
                                TABLE 147 NORTH AMERICA: CALCIUM CARBONATE MARKET, BY COUNTRY, 2022–2030  
                                TABLE 148 EUROPE: CALCIUM CARBONATE MARKET, BY COUNTRY, 2022–2030  
                                TABLE 149 ASIA PACIFIC: CALCIUM CARBONATE MARKET, BY COUNTRY, 2022–2030  
           6.3.5 CALCIUM SULFATE
                    6.3.5.1 Calcium sulfate is a cost-effective, quality-enhancing diluent for solid dosage forms
                                TABLE 150 CALCIUM SULFATE MARKET, BY REGION, 2022–2030  
                                TABLE 151 NORTH AMERICA: CALCIUM SULFATE MARKET, BY COUNTRY, 2022–2030  
                                TABLE 152 EUROPE: CALCIUM SULFATE MARKET, BY COUNTRY, 2022–2030  
                                TABLE 153 ASIA PACIFIC: CALCIUM SULFATE MARKET, BY COUNTRY, 2022–2030  
           6.3.6 OTHER INORGANIC CHEMICALS
                    TABLE 154 OTHER INORGANIC CHEMICALS MARKET, BY REGION, 2022–2030  
                    TABLE 155 NORTH AMERICA: OTHER INORGANIC CHEMICALS MARKET, BY COUNTRY, 2022–2030  
                    TABLE 156 EUROPE: OTHER INORGANIC CHEMICALS MARKET, BY COUNTRY, 2022–2030  
                    TABLE 157 ASIA PACIFIC: OTHER INORGANIC CHEMICALS MARKET, BY COUNTRY, 2022–2030  
    6.4 OTHER CHEMICALS
          TABLE 158 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY REGION, 2022–2030  
          TABLE 159 NORTH AMERICA: MARKET FOR OTHER CHEMICALS, BY COUNTRY, 2022–2030  
          TABLE 160 EUROPE: MARKET FOR OTHER CHEMICALS, BY COUNTRY, 2022–2030  
          TABLE 161 ASIA PACIFIC: MARKET FOR OTHER CHEMICALS, BY COUNTRY, 2022–2030  

7 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY (Page No. - 174)
    7.1 INTRODUCTION
          TABLE 162 GLOBAL MARKET, BY FUNCTIONALITY, 2022–2030  
    7.2 FILLERS & DILUENTS
           7.2.1 DILUENTS OFFER PROPERTIES SUCH AS IMPROVED COHESION, DIRECT COMPRESSION, AND FLOW TO THE FINAL DOSE INTABLETS
                    TABLE 163 GLOBAL MARKET FOR FILLERS & DILUENTS, BY REGION, 2022–2030  
                    TABLE 164 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR FILLERS & DILUENTS, BY COUNTRY, 2022–2030  
                    TABLE 165 EUROPE: MARKET FOR FILLERS & DILUENTS, BY COUNTRY, 2022–2030  
                    TABLE 166 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR FILLERS & DILUENTS, BY COUNTRY, 2022–2030  
    7.3 SUSPENDING & VISCOSITY AGENTS
           7.3.1 SUSPENSIONS OFFER ADVANTAGES SUCH AS DRUG STABILITY AND TASTE MASKING
                    TABLE 167 GLOBAL MARKET FOR SUSPENDING & VISCOSITY AGENTS, BY REGION, 2022–2030  
                    TABLE 168 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUSPENDING & VISCOSITY AGENTS, BY COUNTRY, 2022–2030  
                    TABLE 169 EUROPE: MARKET FOR SUSPENDING & VISCOSITY AGENTS, BY COUNTRY, 2022–2030  
                    TABLE 170 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUSPENDING & VISCOSITY AGENTS, BY COUNTRY, 2022–2030  
    7.4 COATING AGENTS
           7.4.1 INCREASING USE OF SUSTAINED-RELEASE FORMULATIONS IN THE PHARMA INDUSTRY TO DRIVE MARKET GROWTH
                    TABLE 171 PHARMACEUTICAL EXCIPIENTS MARKET FOR COATING AGENTS, BY REGION, 2022–2030  
                    TABLE 172 NORTH AMERICA: MARKET FOR COATING AGENTS, BY COUNTRY, 2022–2030  
                    TABLE 173 EUROPE: MARKET FOR COATING AGENTS, BY COUNTRY, 2022–2030  
                    TABLE 174 ASIA PACIFIC: MARKET FOR COATING AGENTS, BY COUNTRY, 2022–2030  
    7.5 BINDERS
           7.5.1 BINDERS PROVIDE FLUIDITY AND COMPRESSIBILITY ESSENTIAL FOR                     TABLET MANUFACTURING
                    TABLE 175 PHARMACEUTICAL EXCIPIENTS MARKET FOR BINDERS, BY REGION, 2022–2030  
                    TABLE 176 NORTH AMERICA: MARKET FOR BINDERS, BY COUNTRY, 2022–2030  
                    TABLE 177 EUROPE: MARKET FOR BINDERS, BY COUNTRY, 2022–2030  
                    TABLE 178 ASIA PACIFIC: MARKET FOR BINDERS, BY COUNTRY, 2022–2030  
    7.6 FLAVORING AGENTS & SWEETENERS
           7.6.1 FLAVORING AGENTS ARE USED TO IMPROVE THE PALATABILITY OF DRUGS
                    TABLE 179 PHARMACEUTICAL EXCIPIENTS MARKET FOR FLAVORING AGENTS & SWEETENERS, BY REGION, 2022–2030  
                    TABLE 180 NORTH AMERICA: MARKET FOR FLAVORING AGENTS & SWEETENERS, BY COUNTRY, 2022–2030  
                    TABLE 181 EUROPE: MARKET FOR FLAVORING AGENTS & SWEETENERS, BY COUNTRY, 2022–2030  
                    TABLE 182 ASIA PACIFIC: MARKET FOR FLAVORING AGENTS & SWEETENERS, BY COUNTRY, 2022–2030  
    7.7 DISINTEGRANTS
           7.7.1 DISINTEGRANTS CAUSE A RAPID BREAK-UP OF SOLID DOSAGE FORMS
                    TABLE 183 PHARMACEUTICAL EXCIPIENTS MARKET FOR DISINTEGRANTS, BY REGION, 2022–2030  
                    TABLE 184 NORTH AMERICA: MARKET FOR DISINTEGRANTS, BY COUNTRY, 2022–2030  
                    TABLE 185 EUROPE: MARKET FOR DISINTEGRANTS, BY COUNTRY, 2022–2030  
                    TABLE 186 ASIA PACIFIC: MARKET FOR DISINTEGRANTS, BY COUNTRY, 2022–2030  
    7.8 COLORANTS
           7.8.1 COLORING AGENTS ARE USED IN HARD AND SOFT GELATIN CAPSULES, TABLETS, ORAL LIQUIDS, AND TOPICAL CREAMS
                    TABLE 187 PHARMACEUTICAL EXCIPIENTS MARKET FOR COLORANTS, BY REGION, 2022–2030  
                    TABLE 188 NORTH AMERICA: MARKET FOR COLORANTS, BY COUNTRY, 2022–2030  
                    TABLE 189 EUROPE: MARKET FOR COLORANTS, BY COUNTRY, 2022–2030  
                    TABLE 190 ASIA PACIFIC: MARKET FOR COLORANTS, BY COUNTRY, 2022–2030  
    7.9 LUBRICANTS & GLIDANTS
           7.9.1 GLIDANTS IMPROVE THE FLOW PROPERTIES OF A FORMULATION BY REDUCING INTER-PARTICLE FRICTION AND COHESION
                    TABLE 191 PHARMACEUTICAL EXCIPIENTS MARKET FOR LUBRICANTS & GLIDANTS, BY REGION, 2022–2030  
                    TABLE 192 NORTH AMERICA: MARKET FOR LUBRICANTS & GLIDANTS, BY COUNTRY, 2022–2030  
                    TABLE 193 EUROPE: MARKET FOR LUBRICANTS & GLIDANTS, BY COUNTRY, 2022–2030  
                    TABLE 194 ASIA PACIFIC: MARKET FOR LUBRICANTS & GLIDANTS, BY COUNTRY, 2022–2030  
    7.10 PRESERVATIVES
           7.10.1 BENZYL ALCOHOL IS A WIDELY USED PRESERVATIVE IN THE PHARMACEUTICAL AND NUTRACEUTICAL INDUSTRY
                    TABLE 195 PHARMACEUTICAL EXCIPIENTS MARKET FOR PRESERVATIVES, BY REGION, 2022–2030  
                    TABLE 196 NORTH AMERICA: MARKET FOR PRESERVATIVES, BY COUNTRY, 2022–2030  
                    TABLE 197 EUROPE: MARKET FOR PRESERVATIVES, BY COUNTRY, 2022–2030  
                    TABLE 198 ASIA PACIFIC: MARKET FOR PRESERVATIVES, BY COUNTRY, 2022–2030  
    7.11 EMULSIFYING AGENTS
           7.11.1 USE OF SOLUBILITY ENHANCEMENT EXCIPIENTS IN LIQUID DRUG FORMULATIONS HELPS INCREASE API BIOAVAILABILITY
                    TABLE 199 PHARMACEUTICAL EXCIPIENTS MARKET FOR EMULSIFYING AGENTS, BY REGION, 2022–2030  
                    TABLE 200 NORTH AMERICA: MARKET FOR EMULSIFYING AGENTS, BY COUNTRY, 2022–2030  
                    TABLE 201 EUROPE: MARKET FOR EMULSIFYING AGENTS, BY COUNTRY, 2022–2030  
                    TABLE 202 ASIA PACIFIC: MARKET FOR EMULSIFYING AGENTS, BY COUNTRY, 2022–2030  
    7.12 OTHER FUNCTIONALITIES
          TABLE 203 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY REGION, 2022–2030  
          TABLE 204 NORTH AMERICA: MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2022–2030  
          TABLE 205 EUROPE: MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2022–2030  
          TABLE 206 ASIA PACIFIC: MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2022–2030  

8 PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION (Page No. - 195)
    8.1 INTRODUCTION
          TABLE 207 PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2022–2030  
    8.2 ORAL FORMULATIONS
          TABLE 208 GLOBAL MARKET FOR ORAL FORMULATIONS, BY REGION, 2022–2030  
          TABLE 209 NORTH AMERICA: MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2022–2030  
          TABLE 210 EUROPE: MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2022–2030  
          TABLE 211 ASIA PACIFIC: MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2022–2030  
          TABLE 212 MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2030  
           8.2.1 TABLETS
                    8.2.1.1 Tablets are the most widely used dosage forms
                                TABLE 213 TYPICAL COMPOSITION OF TABLETS
                                TABLE 214 PHARMACEUTICAL EXCIPIENTS MARKET FOR TABLETS, BY REGION, 2022–2030  
                                TABLE 215 NORTH AMERICA: MARKET FOR TABLETS, BY COUNTRY, 2022–2030  
                                TABLE 216 EUROPE: MARKET FOR TABLETS, BY COUNTRY, 2022–2030  
                                TABLE 217 ASIA PACIFIC: MARKET FOR TABLETS, BY COUNTRY, 2022–2030  
           8.2.2 CAPSULES
                    TABLE 218 PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY REGION, 2022–2030  
                    TABLE 219 NORTH AMERICA: MARKET FOR CAPSULES, BY COUNTRY, 2022–2030  
                    TABLE 220 EUROPE: MARKET FOR CAPSULES, BY COUNTRY, 2022–2030  
                    TABLE 221 ASIA PACIFIC: MARKET FOR CAPSULES, BY COUNTRY, 2022–2030  
                    TABLE 222 PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2022–2030  
                    8.2.2.1 Hard-gelatin capsules
                               8.2.2.1.1 Ease of manufacturing and versatility are driving the growth of the hard-gelatin capsules market
                                              TABLE 223 HARD-GELATIN CAPSULES MARKET, BY REGION, 2022–2030  
                                              TABLE 224 NORTH AMERICA: HARD-GELATIN CAPSULES MARKET, BY COUNTRY, 2022–2030  
                                              TABLE 225 EUROPE: HARD-GELATIN CAPSULES MARKET, BY COUNTRY, 2022–2030  
                                              TABLE 226 ASIA PACIFIC: HARD-GELATIN CAPSULES MARKET, BY COUNTRY, 2022–2030  
                    8.2.2.2 Soft-gelatin capsules
                               8.2.2.2.1 Stability concerns with highly water-soluble compounds and compounds susceptible to hydrolysis have restricted market growth
                                              TABLE 227 SOFT-GELATIN CAPSULES MARKET, BY REGION, 2022–2030  
                                              TABLE 228 NORTH AMERICA: SOFT-GELATIN CAPSULES MARKET, BY COUNTRY, 2022–2030  
                                              TABLE 229 EUROPE: SOFT-GELATIN CAPSULES MARKET, BY COUNTRY, 2022–2030  
                                              TABLE 230 ASIA PACIFIC: SOFT-GELATIN CAPSULES MARKET, BY COUNTRY, 2022–2030  
           8.2.3 LIQUID FORMULATIONS
                    8.2.3.1 Liquid formulations require no dissolution time and boast faster absorption from the stomach than tablets
                                TABLE 231 PHARMACEUTICAL EXCIPIENTS MARKET FOR LIQUID FORMULATIONS, BY REGION, 2022–2030  
                                TABLE 232 NORTH AMERICA: MARKET FOR LIQUID FORMULATIONS, BY COUNTRY, 2022–2030  
                                TABLE 233 EUROPE: MARKET FOR LIQUID FORMULATIONS, BY COUNTRY, 2022–2030  
                                TABLE 234 ASIA PACIFIC: MARKET FOR LIQUID FORMULATIONS, BY COUNTRY, 2022–2030  
    8.3 TOPICAL FORMULATIONS
           8.3.1 ADVANTAGES OF TOPICAL DRUG DELIVERY ARE DRIVING THE DEMAND FOR EXCIPIENTS IN THIS SEGMENT
                    TABLE 235 PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY REGION, 2022–2030  
                    TABLE 236 NORTH AMERICA: MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY, 2022–2030  
                    TABLE 237 EUROPE: MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY, 2022–2030  
                    TABLE 238 ASIA PACIFIC: MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY, 2022–2030  
    8.4 PARENTERAL FORMULATIONS
           8.4.1 EMERGENCE OF NEW BIOLOGICAL MOLECULES INCREASES THE DEMAND FOR EXCIPIENTS
                    TABLE 239 TYPICAL COMPOSITION OF PARENTERAL FORMULATIONS
                    TABLE 240 EXCIPIENTS USED IN PARENTERAL FORMULATIONS
                    TABLE 241 PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY REGION, 2022–2030  
                    TABLE 242 NORTH AMERICA: MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2022–2030  
                    TABLE 243 EUROPE: MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2022–2030  
                    TABLE 244 ASIA PACIFIC: MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2022–2030  
    8.5 OTHER FORMULATIONS
          TABLE 245 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY REGION, 2022–2030  
          TABLE 246 NORTH AMERICA: MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2022–2030  
          TABLE 247 EUROPE: MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2022–2030  
          TABLE 248 ASIA PACIFIC: MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2022–2030  

9 PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION (Page No. - 215)
    9.1 INTRODUCTION
          TABLE 249 GLOBAL MARKET, BY REGION, 2022–2030  
    9.2 EUROPE
          FIGURE 34 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET SNAPSHOT
          TABLE 250 EUROPE: MARKET, BY COUNTRY, 2022–2030  
          TABLE 251 EUROPE: MARKET, BY PRODUCT, 2022–2030  
          TABLE 252 EUROPE: MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2022–2030  
          TABLE 253 EUROPE: OLEOCHEMICALS MARKET, BY TYPE, 2022–2030  
          TABLE 254 EUROPE: CARBOHYDRATES MARKET, BY TYPE, 2022–2030  
          TABLE 255 EUROPE: SUGARS MARKET, BY TYPE, 2022–2030  
          TABLE 256 EUROPE: ACTUAL SUGARS MARKET, BY TYPE, 2022–2030  
          TABLE 257 EUROPE: SUGAR ALCOHOLS MARKET, BY TYPE, 2022–2030  
          TABLE 258 EUROPE: CELLULOSE MARKET, BY TYPE, 2022–2030  
          TABLE 259 EUROPE: STARCH MARKET, BY TYPE, 2022–2030  
          TABLE 260 EUROPE: PETROCHEMICALS MARKET, BY TYPE, 2022–2030  
          TABLE 261 EUROPE: GLYCOLS MARKET, BY TYPE, 2022–2030  
          TABLE 262 EUROPE: MINERAL HYDROCARBONS MARKET, BY TYPE, 2022–2030  
          TABLE 263 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2022–2030  
          TABLE 264 EUROPE: MARKET, BY FUNCTIONALITY, 2022–2030  
          TABLE 265 EUROPE: MARKET, BY FORMULATION, 2022–2030  
          TABLE 266 EUROPE: MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2030  
          TABLE 267 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2022–2030  
           9.2.1 GERMANY
                    9.2.1.1 Germany accounted for the largest share of the European pharmaceutical excipients market in 2021
                                TABLE 268 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2022–2030  
                                TABLE 269 GERMANY: MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2022–2030  
                                TABLE 270 GERMANY: OLEOCHEMICALS MARKET, BY TYPE, 2022–2030  
                                TABLE 271 GERMANY: CARBOHYDRATES MARKET, BY TYPE, 2022–2030  
                                TABLE 272 GERMANY: SUGARS MARKET, BY TYPE, 2022–2030  
                                TABLE 273 GERMANY: ACTUAL SUGARS MARKET, BY TYPE, 2022–2030  
                                TABLE 274 GERMANY: SUGAR ALCOHOLS MARKET, BY TYPE, 2022–2030  
                                TABLE 275 GERMANY: CELLULOSE MARKET, BY TYPE, 2022–2030  
                                TABLE 276 GERMANY: STARCH MARKET, BY TYPE, 2022–2030  
                                TABLE 277 GERMANY: PETROCHEMICALS MARKET, BY TYPE, 2022–2030  
                                TABLE 278 GERMANY: GLYCOLS MARKET, BY TYPE, 2022–2030  
                                TABLE 279 GERMANY: MINERAL HYDROCARBONS MARKET, BY TYPE, 2022–2030  
                                TABLE 280 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2022–2030  
                                TABLE 281 GERMANY: MARKET, BY FUNCTIONALITY, 2022–2030  
                                TABLE 282 GERMANY: MARKET, BY FORMULATION, 2022–2030  
                                TABLE 283 GERMANY: MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2030  
                                TABLE 284 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2022–2030  
           9.2.2 FRANCE
                    9.2.2.1 Large geriatric population in the country to support market growth
                                TABLE 285 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2022–2030  
                                TABLE 286 FRANCE: MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2022–2030  
                                TABLE 287 FRANCE: OLEOCHEMICALS MARKET, BY TYPE, 2022–2030  
                                TABLE 288 FRANCE: CARBOHYDRATES MARKET, BY TYPE, 2022–2030  
                                TABLE 289 FRANCE: SUGARS MARKET, BY TYPE, 2022–2030  
                                TABLE 290 FRANCE: ACTUAL SUGARS MARKET, BY TYPE, 2022–2030  
                                TABLE 291 FRANCE: SUGAR ALCOHOLS MARKET, BY TYPE, 2022–2030  
                                TABLE 292 FRANCE: CELLULOSE MARKET, BY TYPE, 2022–2030  
                                TABLE 293 FRANCE: STARCH MARKET, BY TYPE, 2022–2030  
                                TABLE 294 FRANCE: PETROCHEMICALS MARKET, BY TYPE, 2022–2030  
                                TABLE 295 FRANCE: GLYCOLS MARKET, BY TYPE, 2022–2030  
                                TABLE 296 FRANCE: MINERAL HYDROCARBONS MARKET, BY TYPE, 2022–2030  
                                TABLE 297 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2022–2030  
                                TABLE 298 FRANCE: MARKET, BY FUNCTIONALITY, 2022–2030  
                                TABLE 299 FRANCE: MARKET, BY FORMULATION, 2022–2030  
                                TABLE 300 FRANCE: MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2030  
                                TABLE 301 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2022–2030  
           9.2.3 UK
                    9.2.3.1 Growing adoption of generics and the development of novel multi-functional, co-processed excipients to drive market growth
                                TABLE 302 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2022–2030  
                                TABLE 303 UK: MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2022–2030  
                                TABLE 304 UK: OLEOCHEMICALS MARKET, BY TYPE, 2022–2030  
                                TABLE 305 UK: CARBOHYDRATES MARKET, BY TYPE, 2022–2030  
                                TABLE 306 UK: SUGARS MARKET, BY TYPE, 2022–2030  
                                TABLE 307 UK: ACTUAL SUGARS MARKET, BY TYPE, 2022–2030  
                                TABLE 308 UK: SUGAR ALCOHOLS MARKET, BY TYPE, 2022–2030  
                                TABLE 309 UK: CELLULOSE MARKET, BY TYPE, 2022–2030  
                                TABLE 310 UK: STARCH MARKET, BY TYPE, 2022–2030  
                                TABLE 311 UK: PETROCHEMICALS MARKET, BY TYPE, 2022–2030  
                                TABLE 312 UK: GLYCOLS MARKET, BY TYPE, 2022–2030  
                                TABLE 313 UK: MINERAL HYDROCARBONS MARKET, BY TYPE, 2022–2030  
                                TABLE 314 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2022–2030  
                                TABLE 315 UK: MARKET, BY FUNCTIONALITY, 2022–2030  
                                TABLE 316 UK: MARKET, BY FORMULATION, 2022–2030  
                                TABLE 317 UK: MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2030  
                                TABLE 318 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2022–2030  
           9.2.4 ITALY
                    9.2.4.1 Budgetary constraints and restricted healthcare spending impede the growth of the Italian market
                                TABLE 319 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2022–2030  
                                TABLE 320 ITALY: MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2022–2030  
                                TABLE 321 ITALY: OLEOCHEMICALS MARKET, BY TYPE, 2022–2030  
                                TABLE 322 ITALY: CARBOHYDRATES MARKET, BY TYPE, 2022–2030  
                                TABLE 323 ITALY: SUGARS MARKET, BY TYPE, 2022–2030  
                                TABLE 324 ITALY: ACTUAL SUGARS MARKET, BY TYPE, 2022–2030  
                                TABLE 325 ITALY: SUGAR ALCOHOLS MARKET, BY TYPE, 2022–2030  
                                TABLE 326 ITALY: CELLULOSE MARKET, BY TYPE, 2022–2030  
                                TABLE 327 ITALY: STARCH MARKET, BY TYPE, 2022–2030  
                                TABLE 328 ITALY: PETROCHEMICALS MARKET, BY TYPE, 2022–2030  
                                TABLE 329 ITALY: GLYCOLS MARKET, BY TYPE, 2022–2030  
                                TABLE 330 ITALY: MINERAL HYDROCARBONS MARKET, BY TYPE, 2022–2030  
                                TABLE 331 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2022–2030  
                                TABLE 332 ITALY: MARKET, BY FUNCTIONALITY, 2022–2030  
                                TABLE 333 ITALY: MARKET, BY FORMULATION, 2022–2030  
                                TABLE 334 ITALY: MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2030  
                                TABLE 335 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2022–2030  
           9.2.5 SPAIN
                    9.2.5.1 High consumption of biologics to support market growth
                                TABLE 336 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2022–2030  
                                TABLE 337 SPAIN: MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2022–2030  
                                TABLE 338 SPAIN: OLEOCHEMICALS MARKET, BY TYPE, 2022–2030  
                                TABLE 339 SPAIN: CARBOHYDRATES MARKET, BY TYPE, 2022–2030  
                                TABLE 340 SPAIN: SUGARS MARKET, BY TYPE, 2022–2030  
                                TABLE 341 SPAIN: ACTUAL SUGARS MARKET, BY TYPE, 2022–2030  
                                TABLE 342 SPAIN: SUGAR ALCOHOLS MARKET, BY TYPE, 2022–2030  
                                TABLE 343 SPAIN: CELLULOSE MARKET, BY TYPE, 2022–2030  
                                TABLE 344 SPAIN: STARCH MARKET, BY TYPE, 2022–2030  
                                TABLE 345 SPAIN: PETROCHEMICALS MARKET, BY TYPE, 2022–2030  
                                TABLE 346 SPAIN: GLYCOLS MARKET, BY TYPE, 2022–2030  
                                TABLE 347 SPAIN: MINERAL HYDROCARBONS MARKET, BY TYPE, 2022–2030  
                                TABLE 348 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2022–2030  
                                TABLE 349 SPAIN: MARKET, BY FUNCTIONALITY, 2022–2030  
                                TABLE 350 SPAIN: MARKET, BY FORMULATION, 2022–2030  
                                TABLE 351 SPAIN: MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2030  
                                TABLE 352 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2022–2030  
           9.2.6 REST OF EUROPE
                    TABLE 353 ROE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2022–2030  
                    TABLE 354 ROE: MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2022–2030  
                    TABLE 355 ROE: OLEOCHEMICALS MARKET, BY TYPE, 2022–2030  
                    TABLE 356 ROE: CARBOHYDRATES MARKET, BY TYPE, 2022–2030  
                    TABLE 357 ROE: SUGARS MARKET, BY TYPE, 2022–2030  
                    TABLE 358 ROE: ACTUAL SUGARS MARKET, BY TYPE, 2022–2030  
                    TABLE 359 ROE: SUGAR ALCOHOLS MARKET, BY TYPE, 2022–2030  
                    TABLE 360 ROE: CELLULOSE MARKET, BY TYPE, 2022–2030  
                    TABLE 361 ROE: STARCH MARKET, BY TYPE, 2022–2030  
                    TABLE 362 ROE: PETROCHEMICALS MARKET, BY TYPE, 2022–2030  
                    TABLE 363 ROE: GLYCOLS MARKET, BY TYPE, 2022–2030  
                    TABLE 364 ROE: MINERAL HYDROCARBONS MARKET, BY TYPE, 2022–2030  
                    TABLE 365 ROE: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2022–2030  
                    TABLE 366 ROE: MARKET, BY FUNCTIONALITY, 2022–2030  
                    TABLE 367 ROE: MARKET, BY FORMULATION, 2022–2030  
                    TABLE 368 ROE: MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2030  
                    TABLE 369 ROE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2022–2030  
    9.3 NORTH AMERICA
          FIGURE 35 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET SNAPSHOT
          TABLE 370 NORTH AMERICA: MARKET, BY COUNTRY, 2022–2030  
          TABLE 371 NORTH AMERICA: MARKET, BY PRODUCT, 2022–2030  
          TABLE 372 NORTH AMERICA: MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2022–2030  
          TABLE 373 NORTH AMERICA: OLEOCHEMICALS MARKET, BY TYPE, 2022–2030  
          TABLE 374 NORTH AMERICA: CARBOHYDRATES MARKET, BY TYPE, 2022–2030  
          TABLE 375 NORTH AMERICA: SUGARS MARKET, BY TYPE, 2022–2030  
          TABLE 376 NORTH AMERICA: ACTUAL SUGARS MARKET, BY TYPE, 2022–2030  
          TABLE 377 NORTH AMERICA: SUGAR ALCOHOLS MARKET, BY TYPE, 2022–2030  
          TABLE 378 NORTH AMERICA: CELLULOSE MARKET, BY TYPE, 2022–2030  
          TABLE 379 NORTH AMERICA: STARCH MARKET, BY TYPE, 2022–2030  
          TABLE 380 NORTH AMERICA: PETROCHEMICALS MARKET, BY TYPE, 2022–2030  
          TABLE 381 NORTH AMERICA: GLYCOLS MARKET, BY TYPE, 2022–2030  
          TABLE 382 NORTH AMERICA: MINERAL HYDROCARBONS MARKET, BY TYPE, 2022–2030  
          TABLE 383 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2022–2030  
          TABLE 384 NORTH AMERICA: MARKET, BY FUNCTIONALITY, 2022–2030  
          TABLE 385 NORTH AMERICA: MARKET, BY FORMULATION, 2022–2030  
          TABLE 386 NORTH AMERICA: MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2030  
          TABLE 387 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2022–2030  
           9.3.1 US
                    9.3.1.1 The US dominates the North American market
                                TABLE 388 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2022–2030  
                                TABLE 389 US: MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2022–2030  
                                TABLE 390 US: OLEOCHEMICALS MARKET, BY TYPE, 2022–2030  
                                TABLE 391 US: CARBOHYDRATES MARKET, BY TYPE, 2022–2030  
                                TABLE 392 US: SUGARS MARKET, BY TYPE, 2022–2030  
                                TABLE 393 US: ACTUAL SUGARS MARKET, BY TYPE, 2022–2030  
                                TABLE 394 US: SUGAR ALCOHOLS MARKET, BY TYPE, 2022–2030  
                                TABLE 395 US: CELLULOSE MARKET, BY TYPE, 2022–2030  
                                TABLE 396 US: STARCH MARKET, BY TYPE, 2022–2030  
                                TABLE 397 US: PETROCHEMICALS MARKET, BY TYPE, 2022–2030  
                                TABLE 398 US: GLYCOLS MARKET, BY TYPE, 2022–2030  
                                TABLE 399 US: MINERAL HYDROCARBONS MARKET, BY TYPE, 2022–2030  
                                TABLE 400 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2022–2030  
                                TABLE 401 US: MARKET, BY FUNCTIONALITY, 2022–2030  
                                TABLE 402 US: MARKET, BY FORMULATION, 2022–2030  
                                TABLE 403 US: MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2030  
                                TABLE 404 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2022–2030  
           9.3.2 CANADA
                    9.3.2.1 Strong growth of the emerging markets and slowdown in new product approvals hamper the market growth in Canada
                                TABLE 405 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2022–2030  
                                TABLE 406 CANADA: MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2022–2030  
                                TABLE 407 CANADA: OLEOCHEMICALS MARKET, BY TYPE, 2022–2030  
                                TABLE 408 CANADA: CARBOHYDRATES MARKET, BY TYPE, 2022–2030  
                                TABLE 409 CANADA: SUGARS MARKET, BY TYPE, 2022–2030  
                                TABLE 410 CANADA: ACTUAL SUGARS MARKET, BY TYPE, 2022–2030  
                                TABLE 411 CANADA: SUGAR ALCOHOLS MARKET, BY TYPE, 2022–2030  
                                TABLE 412 CANADA: CELLULOSE MARKET, BY TYPE, 2022–2030  
                                TABLE 413 CANADA: STARCH MARKET, BY TYPE, 2022–2030  
                                TABLE 414 CANADA: PETROCHEMICALS MARKET, BY TYPE, 2022–2030  
                                TABLE 415 CANADA: GLYCOLS MARKET, BY TYPE, 2022–2030  
                                TABLE 416 CANADA: MINERAL HYDROCARBONS MARKET, BY TYPE, 2022–2030  
                                TABLE 417 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2022–2030  
                                TABLE 418 CANADA: MARKET, BY FUNCTIONALITY, 2022–2030  
                                TABLE 419 CANADA: MARKET, BY FORMULATION, 2022–2030  
                                TABLE 420 CANADA: MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2030  
                                TABLE 421 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2022–2030  
    9.4 ASIA PACIFIC
          TABLE 422 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2022–2030  
          TABLE 423 ASIA PACIFIC: MARKET, BY PRODUCT, 2022–2030  
          TABLE 424 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2022–2030  
          TABLE 425 ASIA PACIFIC: OLEOCHEMICALS MARKET, BY TYPE, 2022–2030  
          TABLE 426 ASIA PACIFIC: CARBOHYDRATES MARKET, BY TYPE, 2022–2030  
          TABLE 427 ASIA PACIFIC: SUGARS MARKET, BY TYPE, 2022–2030  
          TABLE 428 ASIA PACIFIC: ACTUAL SUGARS MARKET, BY TYPE, 2022–2030  
          TABLE 429 ASIA PACIFIC: SUGAR ALCOHOLS MARKET, BY TYPE, 2022–2030  
          TABLE 430 ASIA PACIFIC: CELLULOSE MARKET, BY TYPE, 2022–2030  
          TABLE 431 ASIA PACIFIC: STARCH MARKET, BY TYPE, 2022–2030  
          TABLE 432 ASIA PACIFIC: PETROCHEMICALS MARKET, BY TYPE, 2022–2030  
          TABLE 433 ASIA PACIFIC: GLYCOLS MARKET, BY TYPE, 2022–2030  
          TABLE 434 ASIA PACIFIC: MINERAL HYDROCARBONS MARKET, BY TYPE, 2022–2030  
          TABLE 435 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2022–2030  
          TABLE 436 ASIA PACIFIC: MARKET, BY FUNCTIONALITY, 2022–2030  
          TABLE 437 ASIA PACIFIC: MARKET, BY FORMULATION, 2022–2030  
          TABLE 438 ASIA PACIFIC: MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2030  
          TABLE 439 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2022–2030  
           9.4.1 JAPAN
                    9.4.1.1 The rapid growth of Japan’s geriatric population will greatly drive the demand for pharmaceuticals
                                TABLE 440 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2022–2030  
                                TABLE 441 JAPAN: MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2022–2030  
                                TABLE 442 JAPAN: OLEOCHEMICALS MARKET, BY TYPE, 2022–2030  
                                TABLE 443 JAPAN: CARBOHYDRATES MARKET, BY TYPE, 2022–2030  
                                TABLE 444 JAPAN: SUGARS MARKET, BY TYPE, 2022–2030  
                                TABLE 445 JAPAN: ACTUAL SUGARS MARKET, BY TYPE, 2022–2030  
                                TABLE 446 JAPAN: SUGAR ALCOHOLS MARKET, BY TYPE, 2022–2030  
                                TABLE 447 JAPAN: CELLULOSE MARKET, BY TYPE, 2022–2030  
                                TABLE 448 JAPAN: STARCH MARKET, BY TYPE, 2022–2030  
                                TABLE 449 JAPAN: PETROCHEMICALS MARKET, BY TYPE, 2022–2030  
                                TABLE 450 JAPAN: GLYCOLS MARKET, BY TYPE, 2022–2030  
                                TABLE 451 JAPAN: MINERAL HYDROCARBONS MARKET, BY TYPE, 2022–2030  
                                TABLE 452 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2022–2030  
                                TABLE 453 JAPAN: MARKET, BY FUNCTIONALITY, 2022–2030  
                                TABLE 454 JAPAN: MARKET, BY FORMULATION, 2022–2030  
                                TABLE 455 JAPAN: MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2030  
                                TABLE 456 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2022–2030  
           9.4.2 CHINA
                    9.4.2.1 Emphasis on generics and off-patent drugs to drive the market in China
                                TABLE 457 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2022–2030  
                                TABLE 458 CHINA: MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2022–2030  
                                TABLE 459 CHINA: OLEOCHEMICALS MARKET, BY TYPE, 2022–2030  
                                TABLE 460 CHINA: CARBOHYDRATES MARKET, BY TYPE, 2022–2030  
                                TABLE 461 CHINA: SUGARS MARKET, BY TYPE, 2022–2030  
                                TABLE 462 CHINA: ACTUAL SUGARS MARKET, BY TYPE, 2022–2030  
                                TABLE 463 CHINA: SUGAR ALCOHOLS MARKET, BY TYPE, 2022–2030  
                                TABLE 464 CHINA: CELLULOSE MARKET, BY TYPE, 2022–2030  
                                TABLE 465 CHINA: STARCH MARKET, BY TYPE, 2022–2030  
                                TABLE 466 CHINA: PETROCHEMICALS MARKET, BY TYPE, 2022–2030  
                                TABLE 467 CHINA: GLYCOLS MARKET, BY TYPE, 2022–2030  
                                TABLE 468 CHINA: MINERAL HYDROCARBONS MARKET, BY TYPE, 2022–2030  
                                TABLE 469 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2022–2030  
                                TABLE 470 CHINA: MARKET, BY FUNCTIONALITY, 2022–2030  
                                TABLE 471 CHINA: MARKET, BY FORMULATION, 2022–2030  
                                TABLE 472 CHINA: MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2030  
                                TABLE 473 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2022–2030  
           9.4.3 INDIA
                    9.4.3.1 India is a leading producer of generics
                                TABLE 474 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2022–2030  
                                TABLE 475 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2022–2030  
                                TABLE 476 INDIA: OLEOCHEMICALS MARKET, BY TYPE, 2022–2030  
                                TABLE 477 INDIA: CARBOHYDRATES MARKET, BY TYPE, 2022–2030  
                                TABLE 478 INDIA: SUGARS MARKET, BY TYPE, 2022–2030  
                                TABLE 479 INDIA: ACTUAL SUGARS MARKET, BY TYPE, 2022–2030  
                                TABLE 480 INDIA: SUGAR ALCOHOLS MARKET, BY TYPE, 2022–2030  
                                TABLE 481 INDIA: CELLULOSE MARKET, BY TYPE, 2022–2030  
                                TABLE 482 INDIA: STARCH MARKET, BY TYPE, 2022–2030  
                                TABLE 483 INDIA: PETROCHEMICALS MARKET, BY TYPE, 2022–2030  
                                TABLE 484 INDIA: GLYCOLS MARKET, BY TYPE, 2022–2030  
                                TABLE 485 INDIA: MINERAL HYDROCARBONS MARKET, BY TYPE, 2022–2030  
                                TABLE 486 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2022–2030  
                                TABLE 487 INDIA: MARKET, BY FUNCTIONALITY, 2022–2030  
                                TABLE 488 INDIA: MARKET, BY FORMULATION, 2022–2030  
                                TABLE 489 INDIA: MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2030  
                                TABLE 490 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2022–2030  
           9.4.4 REST OF ASIA PACIFIC
                    TABLE 491 ROAPAC: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2022–2030  
                    TABLE 492 ROAPAC: MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2022–2030  
                    TABLE 493 ROAPAC: OLEOCHEMICALS MARKET, BY TYPE, 2022–2030  
                    TABLE 494 ROAPAC: CARBOHYDRATES MARKET, BY TYPE, 2022–2030  
                    TABLE 495 ROAPAC: SUGARS MARKET, BY TYPE, 2022–2030  
                    TABLE 496 ROAPAC: ACTUAL SUGARS MARKET, BY TYPE, 2022–2030  
                    TABLE 497 ROAPAC: SUGAR ALCOHOLS MARKET, BY TYPE, 2022–2030  
                    TABLE 498 ROAPAC: CELLULOSE MARKET, BY TYPE, 2022–2030  
                    TABLE 499 ROAPAC: STARCH MARKET, BY TYPE, 2022–2030  
                    TABLE 500 ROAPAC: PETROCHEMICALS MARKET, BY TYPE, 2022–2030  
                    TABLE 501 ROAPAC: GLYCOLS MARKET, BY TYPE, 2022–2030  
                    TABLE 502 ROAPAC: MINERAL HYDROCARBONS MARKET, BY TYPE, 2022–2030  
                    TABLE 503 ROAPAC: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2022–2030  
                    TABLE 504 ROAPAC: MARKET, BY FUNCTIONALITY, 2022–2030  
                    TABLE 505 ROAPAC: MARKET, BY FORMULATION, 2022–2030  
                    TABLE 506 ROAPAC: MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2030  
                    TABLE 507 ROAPAC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2022–2030  
    9.5 LATIN AMERICA
           9.5.1 GROWING GERIATRIC POPULATION AND DISEASE PREVALENCE ARE DRIVING MARKET GROWTH
                    TABLE 508 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2022–2030  
                    TABLE 509 LATIN AMERICA: MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2022–2030  
                    TABLE 510 LATIN AMERICA: OLEOCHEMICALS MARKET, BY TYPE, 2022–2030  
                    TABLE 511 LATIN AMERICA: CARBOHYDRATES MARKET, BY TYPE, 2022–2030  
                    TABLE 512 LATIN AMERICA: SUGARS MARKET, BY TYPE, 2022–2030  
                    TABLE 513 LATIN AMERICA: ACTUAL SUGARS MARKET, BY TYPE, 2022–2030  
                    TABLE 514 LATIN AMERICA: SUGAR ALCOHOLS MARKET, BY TYPE, 2022–2030  
                    TABLE 515 LATIN AMERICA: CELLULOSE MARKET, BY TYPE, 2022–2030  
                    TABLE 516 LATIN AMERICA: STARCH MARKET, BY TYPE, 2022–2030  
                    TABLE 517 LATIN AMERICA: PETROCHEMICALS MARKET, BY TYPE, 2022–2030  
                    TABLE 518 LATIN AMERICA: GLYCOLS MARKET, BY TYPE, 2022–2030  
                    TABLE 519 LATIN AMERICA: MINERAL HYDROCARBONS MARKET, BY TYPE, 2022–2030  
                    TABLE 520 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2022–2030  
                    TABLE 521 LATIN AMERICA: MARKET, BY FUNCTIONALITY, 2022–2030  
                    TABLE 522 LATIN AMERICA: MARKET, BY FORMULATION, 2022–2030  
                    TABLE 523 LATIN AMERICA: MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2030  
                    TABLE 524 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2022–2030  
    9.6 MIDDLE EAST AND AFRICA
           9.6.1 UNSATURATED MARKETS IN THE REGION HAVE DRAWN THE ATTENTION OF GLOBAL PLAYERS
                    TABLE 525 MIDDLE EAST & AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2022–2030  
                    TABLE 526 MIDDLE EAST & AFRICA: MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2022–2030  
                    TABLE 527 MIDDLE EAST & AFRICA: OLEOCHEMICALS MARKET, BY TYPE, 2022–2030  
                    TABLE 528 MIDDLE EAST & AFRICA: CARBOHYDRATES MARKET, BY TYPE, 2022–2030  
                    TABLE 529 MIDDLE EAST & AFRICA: SUGARS MARKET, BY TYPE, 2022–2030  
                    TABLE 530 MIDDLE EAST & AFRICA: ACTUAL SUGARS MARKET, BY TYPE, 2022–2030  
                    TABLE 531 MIDDLE EAST & AFRICA: SUGAR ALCOHOLS MARKET, BY TYPE, 2022–2030  
                    TABLE 532 MIDDLE EAST & AFRICA: CELLULOSE MARKET, BY TYPE, 2022–2030  
                    TABLE 533 MIDDLE EAST & AFRICA: STARCH MARKET, BY TYPE, 2022–2030  
                    TABLE 534 MIDDLE EAST & AFRICA: PETROCHEMICALS MARKET, BY TYPE, 2022–2030  
                    TABLE 535 MIDDLE EAST & AFRICA: GLYCOLS MARKET, BY TYPE, 2022–2030  
                    TABLE 536 MIDDLE EAST & AFRICA: MINERAL HYDROCARBONS MARKET, BY TYPE, 2022–2030  
                    TABLE 537 MIDDLE EAST & AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2022–2030  
                    TABLE 538 MIDDLE EAST & AFRICA: MARKET, BY FUNCTIONALITY, 2022–2030  
                    TABLE 539 MIDDLE EAST & AFRICA: MARKET, BY FORMULATION, 2022–2030  
                    TABLE 540 MIDDLE EAST & AFRICA: MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2030  
                    TABLE 541 MIDDLE EAST & AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2022–2030  

10 COMPETITIVE LANDSCAPE (Page No. - 324)
     10.1 INTRODUCTION
     10.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
             FIGURE 36 PHARMACEUTICAL EXCIPIENTS MARKET: STRATEGIES ADOPTED
     10.3 MARKET SHARE ANALYSIS
             FIGURE 37 GLOBAL MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS (2021)
             TABLE 542 GLOBAL MARKET: DEGREE OF COMPETITION
     10.4 REVENUE ANALYSIS
             FIGURE 38 REVENUE ANALYSIS FOR KEY COMPANIES (2019-2021)
     10.5 COMPANY EVALUATION QUADRANT
             FIGURE 39 PHARMACEUTICAL EXCIPIENTS MARKET: COMPANY EVALUATION MATRIX, 2021
             10.5.1 STARS
             10.5.2 EMERGING LEADERS
             10.5.3 PERVASIVE PLAYERS
             10.5.4 PARTICIPANTS
     10.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES
             FIGURE 40 PHARMACEUTICAL EXCIPIENTS MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2021
             10.6.1 PROGRESSIVE COMPANIES
             10.6.2 STARTING BLOCKS
             10.6.3 RESPONSIVE COMPANIES
             10.6.4 DYNAMIC COMPANIES
     10.7 COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
             TABLE 543 PHARMACEUTICAL EXCIPIENTS MARKET: DETAILED LIST OF KEY START-UPS/SMES
             TABLE 544 GLOBAL MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS [START-UPS/SMES]
     10.8 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
             10.8.1 COMPANY FOOTPRINT ANALYSIS (25 COMPANIES)
                        TABLE 545 COMPANY FOOTPRINT ANALYSIS OF KEY PLAYERS IN THE PHARMACEUTICAL EXCIPIENTS MARKET
             10.8.2 COMPANY PRODUCT FOOTPRINT (25 COMPANIES)
                        TABLE 546 PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS IN THE GLOBAL MARKET
             10.8.3 COMPANY FUNCTIONALITY FOOTPRINT (25 COMPANIES)
                        TABLE 547 FUNCTIONALITY FOOTPRINT ANALYSIS OF KEY PLAYERS IN PHARMACEUTICAL EXCIPIENTS MARKET
             10.8.4 COMPANY REGIONAL FOOTPRINT (25 COMPANIES)
                        TABLE 548 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS IN THE GLOBAL MARKET
     10.9 COMPETITIVE SCENARIO AND TRENDS
             10.9.1 PRODUCT LAUNCHES
                        TABLE 549 PHARMACEUTICAL EXCIPIENTS MARKET: PRODUCT LAUNCHES, JANUARY 2019-MAY 2022
             10.9.2 DEALS
                        TABLE 550 GLOBAL MARKET: DEALS, JANUARY 2019-MAY 2022

11 COMPANY PROFILES (Page No. - 340)
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
     11.1 KEY PLAYERS
             11.1.1 INTERNATIONAL FLAVORS & FRAGRANCES INC.
                        TABLE 551 INTERNATIONAL FLAVORS & FRAGRANCES, INC.: BUSINESS OVERVIEW
                        FIGURE 41 INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY SNAPSHOT
             11.1.2 ASHLAND GLOBAL HOLDINGS INC
                        TABLE 552 ASHLAND: BUSINESS OVERVIEW
                        FIGURE 42 ASHLAND: COMPANY SNAPSHOT
             11.1.3 EVONIK INDUSTRIES AG
                        TABLE 553 EVONIK INDUSTRIES: BUSINESS OVERVIEW
                        FIGURE 43 EVONIK INDUSTRIES: COMPANY SNAPSHOT
             11.1.4 BASF SE
                        TABLE 554 BASF SE.: BUSINESS OVERVIEW
                        FIGURE 44 BASF SE.: COMPANY SNAPSHOT
             11.1.5 KERRY GROUP PLC
                        TABLE 555 KERRY GROUP: BUSINESS OVERVIEW
                        FIGURE 45 KERRY GROUP: COMPANY SNAPSHOT
             11.1.6 ROQUETTE FRÈRES
                        TABLE 556 ROQUETTE FRÈRES: BUSINESS OVERVIEW
             11.1.7 MERCK KGAA
                        TABLE 557 MERCK KGAA: BUSINESS OVERVIEW
                        FIGURE 46 MERCK KGAA: COMPANY SNAPSHOT
             11.1.8 ASSOCIATED BRITISH FOODS PLC
                        TABLE 558 ASSOCIATED BRITISH FOODS PLC: BUSINESS OVERVIEW
                        FIGURE 47 ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT
             11.1.9 ARCHER DANIELS MIDLAND (ADM) COMPANY
                        TABLE 559 ARCHER DANIELS MIDLAND (ADM) COMPANY: BUSINESS OVERVIEW
                        FIGURE 48 ARCHER DANIELS MIDLAND COMPANY: COMPANY SNAPSHOT
             11.1.10 WACKER CHEMIE AG
                        TABLE 560 WACKER CHEMIE AG: BUSINESS OVERVIEW
                        FIGURE 49 WACKER CHEMIE AG: COMPANY SNAPSHOT
             11.1.11 AIR LIQUIDE SA
                        TABLE 561 AIR LIQUIDE: BUSINESS OVERVIEW
                        FIGURE 50 AIR LIQUIDE SA: COMPANY SNAPSHOT
             11.1.12 DOW CHEMICALS
                        TABLE 562 DOW CHEMICALS: BUSINESS OVERVIEW
                        FIGURE 51 DOW CHEMICALS: COMPANY SNAPSHOT
     11.2 OTHER PLAYERS
             11.2.1 LUBRIZOL CORPORATION
             11.2.2 COLORCON, INC
             11.2.3 DMV-FONTERRA EXCIPIENTS GMBH & CO. KG
             11.2.4 INNOPHOS HOLDINGS, INC
             11.2.5 JRS PHARMA GMBH & CO. KG
             11.2.6 FINAR LIMITED
             11.2.7 MEGGLE GMBH & CO. KG
             11.2.8 FUJI CHEMICAL INDUSTRIES CO., LTD.
             11.2.9 CAPTISOL
             11.2.10 IDEAL CURES PVT. LTD.
             11.2.11 COREL PHARMA CHEM
             11.2.12 BIOGRUND GMBH
             11.2.13 NITIKA PHARMACEUTICAL SPECIALTIES PVT. LTD.

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX (Page No. - 385)
     12.1 DISCUSSION GUIDE
     12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     12.3 AVAILABLE CUSTOMIZATIONS
     12.4 RELATED REPORTS
     12.5 AUTHOR DETAILS